Emerging issues in invasive prenatal diagnosis: Safety and competency in the post-NIPT era

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 55, Issue 6, 2015, Pages 541-546

  Hui, Lisa ^a,b,c   The, Stephanie ^d,e   McCarthy, Elizabeth A ^a,b   Walker, Susan P ^a,b  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d Australian Association of Obstetrical and Gynaecological Ultrasonologists   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

Author keywords

amniocentesis; aneuploidy; chorionic villi sampling; hepatitis B; prenatal diagnosis; risk

Indexed keywords

AMNIOCENTESIS; ARTICLE; AUSTRALIA; CHORION VILLUS SAMPLING; CHROMOSOMAL MICROARRAY; FEMALE; HEALTH PERSONNEL ATTITUDE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROARRAY ANALYSIS; NON INVASIVE PROCEDURE; NONINVASIVE PRENATAL TESTING; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT SAFETY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SELF REPORT; SEROLOGY; SPONTANEOUS ABORTION; VERTICAL TRANSMISSION; VIRUS LOAD; ABORTION, SPONTANEOUS; ADVERSE EFFECTS; CHROMOSOME ANALYSIS; CLINICAL COMPETENCE; CLINICAL PRACTICE; ECHOGRAPHY; GYNECOLOGY; OBSTETRICS; PREGNANCY; PROCEDURES; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TRANSMISSION; UTILIZATION;

ABORTION, SPONTANEOUS; AMNIOCENTESIS; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; CHORIONIC VILLI SAMPLING; CLINICAL COMPETENCE; CYTOGENETIC ANALYSIS; FEMALE; GYNECOLOGY; HEPATITIS B; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; OBSTETRICS; PRACTICE PATTERNS, PHYSICIANS'; PREGNANCY; PRENATAL DIAGNOSIS; SURVEYS AND QUESTIONNAIRES; ULTRASONOGRAPHY;

EID: 84955174767     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12396     Document Type: Article

References (26)

1. Hui L, Muggli E, Halliday J,. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data. BJOG 2015; ePub ahead of print: doi: 10.1111/1471-0528.13488.
2. Warsof SL, Larion S, Abuhamad AZ,. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat Diagn 2015; ePub ahead of print. doi: 10.1002/pd.4601.
3. Platt LD, Janicki MB, Prosen T, et al,. Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States. Am J Obstet Gynecol 2014; 211: 368 e1-368 e7.
4. Larion S, Warsof SL, Romary L, et al,. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures. Obstet Gynecol 2014; 123: 1303-1310.
5. O'Leary P, Maxwell S, Murch A, Hendrie D,. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies. Aust N Z J Obstet Gynaecol 2013; 53: 425-433.
6. Robson S, Hui L,. National decline in invasive diagnostic procedures in association with combined first trimester and cell-free DNA-based aneuploidy screening. Aust N Z J Obstet Gynaecol 2015; Accepted 19 June 2015. In press.
7. Royal College of Obstetricians and Gynaecologists. Amniocentesis and Chorionic Villus Sampling, 2010. [Accessed 4 May 2015.] Available from URL: https://http://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg8/
8. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Certification in Obstetrical and Gynaecological Ultrasound Training Program Handbook, 2015. [Accessed 4 May 2015.] Available from URL: http://www.ranzcog.edu.au/training-handbooks2.html
9. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Certification in Maternal Fetal Medicine Training Program Handbook, 2015. [Accessed 4 May 2015.] Available from URL: http://www.ranzcog.edu.au/training-handbooks2.html
10. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Annual Report, 2014. [Accessed 4 May 2015.] Available from URL: https://http://www.ranzcog.edu.au/ranzcog-annualreport.html
11. California Department of Public Health. Genetic Disease Screening Program. Prenatal Diagnosis Center Standards and Definitions, 2013. [Accessed 4 May 2015.] Available from URL: http://www.cdph.ca.gov/programs/GDSP/Documents/Standards2013.pdf
12. Halliday JL, Lumley J, Sheffield LJ, et al,. Importance of complete follow-up of spontaneous fetal loss after amniocentesis and chorion villus sampling. Lancet 1992; 340: 886-890.
13. Tabor A, Vestergaard CH, Lidegaard O,. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol 2009; 34: 19-24.
14. Welch RA, Salem-Elgharib S, Wiktor AE, et al,. Operator experience and sample quality in genetic amniocentesis. Am J Obstet Gynecol 2006; 194: 189-191.
15. Blessed WB, Lacoste H, Welch RA,. Obstetrician-gynecologists performing genetic amniocentesis may be misleading themselves and their patients. Am J Obstet Gynecol 2001; 184: 1340-1342.
16. Giles ML, Grace R, Tai A, et al,. Prevention of mother-to-child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: current standards of care. Aust N Z J Obstet Gynaecol 2013; 53: 231-235.
17. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Management of Hepatitis B in Pregnancy, 2013. [Accessed 4 May 2015.] Available from URL: http://www.ranzcog.edu.au/college-statements-guidelines.htmlC-Obs50
18. Yi W, Pan CQ, Hao J, et al,. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J Hepatol 2014; 60: 523-529.
19. British HIV Association. Guidelines for the management of HIV infection in pregnant women. HIV Med. 2012; 13: 87-157.
20. Mandelbrot L, Jasseron C, Ekoukou D, et al,. Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hepatites Virales French Perinatal Cohort. Am J Obstet Gynecol 2009; 200: 160 e1-160 e9.
21. Akolekar R, Beta J, Picciarelli G, et al,. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 16-26.
22. Tabor A, Alfirevic Z,. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010; 27: 1-7.
23. Mujezinovic F, Alfirevic Z,. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007; 110: 687-694.
24. Donnelly JC, Platt LD, Rebarber A, et al,. Association of copy number variants with specific ultrasonographically detected fetal anomalies. Obstet Gynecol 2014; 124: 83-90.
25. Wapner RJ, Martin CL, Levy B, et al,. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012; 367: 2175-2184.
26. Haymon L, Simi E, Moyer K, et al,. Clinical implementation of noninvasive prenatal testing among maternal fetal medicine specialists. Prenat Diagn 2014; 34: 416-423.